215 related articles for article (PubMed ID: 38372422)
1. Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index.
Wang Y; Ma X; Xu E; Huang Z; Yang C; Zhu K; Dong Y; Zhang C
Clin Transl Med; 2024 Feb; 14(2):e1586. PubMed ID: 38372422
[TBL] [Abstract][Full Text] [Related]
2. Squalene epoxidase-induced cholesteryl ester accumulation promotes nasopharyngeal carcinoma development by activating PI3K/AKT signaling.
Li L; Zhang Q; Wang X; Li Y; Xie H; Chen X
Cancer Sci; 2020 Jul; 111(7):2275-2283. PubMed ID: 32314495
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of squalene epoxidase linking with PI3K/AKT signaling pathway suppresses endometrial cancer.
Ma L; Huang W; Liang X; Bai G; Wang X; Jiang H; Xin Y; Hu L; Chen X; Liu C
Cancer Sci; 2023 Sep; 114(9):3595-3607. PubMed ID: 37438885
[TBL] [Abstract][Full Text] [Related]
4. Squalene Epoxidase Metabolic Dependency Is a Targetable Vulnerability in Castration-Resistant Prostate Cancer.
Shangguan X; Ma Z; Yu M; Ding J; Xue W; Qi J
Cancer Res; 2022 Sep; 82(17):3032-3044. PubMed ID: 35767703
[TBL] [Abstract][Full Text] [Related]
5. Targeting Squalene Epoxidase Confers Metabolic Vulnerability and Overcomes Chemoresistance in HNSCC.
Zhao X; Guo B; Sun W; Yu J; Cui L
Adv Sci (Weinh); 2023 Sep; 10(27):e2206878. PubMed ID: 37490552
[TBL] [Abstract][Full Text] [Related]
6. Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target.
Liu D; Wong CC; Fu L; Chen H; Zhao L; Li C; Zhou Y; Zhang Y; Xu W; Yang Y; Wu B; Cheng G; Lai PB; Wong N; Sung JJY; Yu J
Sci Transl Med; 2018 Apr; 10(437):. PubMed ID: 29669855
[TBL] [Abstract][Full Text] [Related]
7. Squalene epoxidase promotes hepatocellular carcinoma development by activating STRAP transcription and TGF-β/SMAD signalling.
Zhang Z; Wu W; Jiao H; Chen Y; Ji X; Cao J; Yin F; Yin W
Br J Pharmacol; 2023 Jun; 180(12):1562-1581. PubMed ID: 36581319
[TBL] [Abstract][Full Text] [Related]
8. Squalene epoxidase/SQLE is a candidate target for treatment of colorectal cancers with
Du Y; Rokavec M; Hermeking H
Int J Biol Sci; 2023; 19(13):4103-4122. PubMed ID: 37705742
[TBL] [Abstract][Full Text] [Related]
9. SQLE promotes pancreatic cancer growth by attenuating ER stress and activating lipid rafts-regulated Src/PI3K/Akt signaling pathway.
Xu R; Song J; Ruze R; Chen Y; Yin X; Wang C; Zhao Y
Cell Death Dis; 2023 Aug; 14(8):497. PubMed ID: 37542052
[TBL] [Abstract][Full Text] [Related]
10. Squalene epoxidase promotes the proliferation and metastasis of lung squamous cell carcinoma cells though extracellular signal-regulated kinase signaling.
Ge H; Zhao Y; Shi X; Tan Z; Chi X; He M; Jiang G; Ji L; Li H
Thorac Cancer; 2019 Mar; 10(3):428-436. PubMed ID: 30734525
[TBL] [Abstract][Full Text] [Related]
11. Reduction of Squalene Epoxidase by Cholesterol Accumulation Accelerates Colorectal Cancer Progression and Metastasis.
Jun SY; Brown AJ; Chua NK; Yoon JY; Lee JJ; Yang JO; Jang I; Jeon SJ; Choi TI; Kim CH; Kim NS
Gastroenterology; 2021 Mar; 160(4):1194-1207.e28. PubMed ID: 32946903
[TBL] [Abstract][Full Text] [Related]
12. Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer.
Brown DN; Caffa I; Cirmena G; Piras D; Garuti A; Gallo M; Alberti S; Nencioni A; Ballestrero A; Zoppoli G
Sci Rep; 2016 Jan; 6():19435. PubMed ID: 26777065
[TBL] [Abstract][Full Text] [Related]
13. Squalene epoxidase promotes colorectal cancer cell proliferation through accumulating calcitriol and activating CYP24A1-mediated MAPK signaling.
He L; Li H; Pan C; Hua Y; Peng J; Zhou Z; Zhao Y; Lin M
Cancer Commun (Lond); 2021 Aug; 41(8):726-746. PubMed ID: 34268906
[TBL] [Abstract][Full Text] [Related]
14. SQLE is a promising prognostic and immunological biomarker and correlated with immune Infiltration in Sarcoma.
Shao M; Wang M; Wang X; Feng X; Zhang L; Lv H
Medicine (Baltimore); 2024 Feb; 103(6):e37030. PubMed ID: 38335381
[TBL] [Abstract][Full Text] [Related]
15. Targeting Squalene Epoxidase Interrupts Homologous Recombination via the ER Stress Response and Promotes Radiotherapy Efficacy.
Hong Z; Liu T; Wan L; Fa P; Kumar P; Cao Y; Prasad CB; Qiu Z; Liu J; Wang H; Li Z; Wang QE; Guo P; Guo D; Yilmaz AS; Lu L; Papandreou I; Jacob NK; Yan C; Zhang X; She QB; Ma Z; Zhang J
Cancer Res; 2022 Apr; 82(7):1298-1312. PubMed ID: 35045984
[TBL] [Abstract][Full Text] [Related]
16. Squalene Epoxidase Induces Nonalcoholic Steatohepatitis Via Binding to Carbonic Anhydrase III and is a Therapeutic Target.
Liu D; Wong CC; Zhou Y; Li C; Chen H; Ji F; Go MYY; Wang F; Su H; Wei H; Cai Z; Wong N; Wong VWS; Yu J
Gastroenterology; 2021 Jun; 160(7):2467-2482.e3. PubMed ID: 33647280
[TBL] [Abstract][Full Text] [Related]
17. SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma.
You W; Ke J; Chen Y; Cai Z; Huang ZP; Hu P; Wu X
Front Immunol; 2022; 13():864244. PubMed ID: 35720314
[TBL] [Abstract][Full Text] [Related]
18. Squalene synthase predicts poor prognosis in stage I-III colon adenocarcinoma and synergizes squalene epoxidase to promote tumor progression.
Jiang H; Tang E; Chen Y; Liu H; Zhao Y; Lin M; He L
Cancer Sci; 2022 Mar; 113(3):971-985. PubMed ID: 34939274
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of SQLE Contributes to Poor Survival in Head and Neck Squamous Cell Carcinoma.
Li J; Yang T; Wang Q; Li Y; Wu H; Zhang M; Qi H; Zhang H; Li J
Int J Biol Sci; 2022; 18(9):3576-3591. PubMed ID: 35813482
[TBL] [Abstract][Full Text] [Related]
20. SQLE inhibition suppresses the development of pancreatic ductal adenocarcinoma and enhances its sensitivity to chemotherapeutic agents in vitro.
Zhao F; Huang Y; Zhang Y; Li X; Chen K; Long Y; Li F; Ma X
Mol Biol Rep; 2022 Jul; 49(7):6613-6621. PubMed ID: 35552960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
